Harbour BioMed acquires Spruce Bio

Harbour BioMed agreed to acquire Spruce Bio. Reported deal value: Undisclosed. Status: Announced. Sector: biopharmaceutical. Target headquarters context: South San Francisco, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-19. Figures and status may change as filings and press coverage update.

Harbour BioMed , a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that through its wholly-owned subsidiary, it has exercised its warrant to acquire the common stock in Spruce Biosciences , Inc.